http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-634583-A5
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J3-005 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00 |
filingDate | 1982-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f290b9c175af730677d873395095f01 |
publicationDate | 1983-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CH-634583-A5 |
titleOfInvention | Process for the preparation of novel androstadiene-17 beta -carboxylic acid esters |
abstract | There is described a process for the preparation of novel androstadiene-17 beta -carboxylic acid esters of the formula <IMAGE> in which R denotes the radical of an alcohol ROH of the aliphatic, araliphatic or heterocyclic series having 1-10 C atoms, R' denotes a hydroxyl group which is free or esterified with a carboxylic acid having at most 7 C atoms, R'' denotes an alpha - or beta -methyl group or the methylene group or R' with R'' together denote the 16 alpha ,17 alpha -dihydroxyacetonide group <IMAGE> X denotes chlorine and Y denotes chlorine or fluorine. The compounds of the formula (I) have anti-inflammatory activity. According to the invention, they are obtained by converting a carboxylic acid of the formula (I), in which R represents hydrogen and the other substituents have the abovementioned meanings, or a salt thereof or a functional derivative thereof which can be converted into an ester into the carboxylic acid ester. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4820700-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0143764-A1 |
priorityDate | 1977-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.